Cargando…
A Curcumin Analog Exhibits Multiple Biologic Effects on the Pathogenesis of Alzheimer’s Disease and Improves Behavior, Inflammation, and β-Amyloid Accumulation in a Mouse Model
Drugs for the treatment of Alzheimer’s disease (AD) are in urgent demand due to the unmet need and the social burden associated with the disease. Curcumin has been historically considered as a beneficial product for anti-aging and AD. However, many efforts to develop curcumin for clinical use are hi...
Autores principales: | Su, Ih-Jen, Chang, Hong-Yi, Wang, Hui-Chen, Tsai, Kuen-Jer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432838/ https://www.ncbi.nlm.nih.gov/pubmed/32751716 http://dx.doi.org/10.3390/ijms21155459 |
Ejemplares similares
-
A Chemical Analog of Curcumin as an Improved Inhibitor of Amyloid Abeta Oligomerization
por: Orlando, Robert A., et al.
Publicado: (2012) -
The Beneficial Effects of Combining Anti-Aβ Antibody NP106 and Curcumin Analog TML-6 on the Treatment of Alzheimer’s Disease in APP/PS1 Mice
por: Su, Ih-Jen, et al.
Publicado: (2022) -
Curcumin and Novel Synthetic Analogs in Cell-Based Studies of Alzheimer’s Disease
por: Gagliardi, Stella, et al.
Publicado: (2018) -
Curcumin Analogs Reduce Stress and Inflammation Indices in Experimental Models of Diabetes
por: Biswas, Saumik, et al.
Publicado: (2019) -
Novel Chemically Modified Curcumin (CMC) Analogs Exhibit Anti-Melanogenic Activity in Primary Human Melanocytes
por: Goenka, Shilpi, et al.
Publicado: (2021)